900000000000489007: Concept inactivation indicator attribute value reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Attribute value type\Concept inactivation indicator reference set

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Concept inactivation indicator reference set	Is a	Attribute value type	true	Inferred relationship	Some

Members	valueId
Anthrax serology	Ambiguous
Anthrax serology	Ambiguous
Anthrax spore vaccine	Moved elsewhere
Anthrax vaccine	Ambiguous
Anthrax vaccine	Ambiguous
Anthrax vaccine injection solution 0.5mL ampule	Ambiguous
Anthrax vaccine, adsorbed 5mL injection	Ambiguous
Anthrax vaccine, adsorbed injection solution 5mL vial	Ambiguous
Anthropologist	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anthropophilic fungus	A component that fails to comply with the current editorial guidance.
Anthropozoophilic fungus	A component that fails to comply with the current editorial guidance.
Anti A1	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti DNase test	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti HBc IgG level	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti HBc IgG level	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti HBc IgM level	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti HBc IgM level	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti I	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti PM-SCI antibody	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti RNP antibody	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti SM antibody	Ambiguous
Anti centromere antibody	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti glaucoma agent	A component that fails to comply with the current editorial guidance.
Anti i	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti rickettsial antibody	A component that fails to comply with the current editorial guidance.
Anti smooth muscle antibody titre	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti smooth muscle autoantibod	Ambiguous
Anti smooth muscle autoantibod (& level)	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-B antibody	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-B autoantibody level	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-CMV i-v immunoglobulin (& [injection])	Ambiguous
Anti-CMV intravenous immunoglobulin injection	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-D (Rh) immunoglobulin 1250iu/mL injection solution 1mL prefilled syringe	A component that is no longer current, useful, appropriate or acceptable.
Anti-D (Rh) immunoglobulin 1500iu powder and solvent for injection solution vial	A component that fails to comply with the current editorial guidance.
Anti-D (Rh) immunoglobulin 1500iu powder for conventional release solution for injection vial	A component that fails to comply with the current editorial guidance.
Anti-D (Rh) immunoglobulin 1500iu prefilled 2mL syringe	A component that fails to comply with the current editorial guidance.
Anti-D (Rh) immunoglobulin 1500iu prefilled syringe	A component that fails to comply with the current editorial guidance.
Anti-D (Rh) immunoglobulin 2500iu injection solution vial	A component that fails to comply with the current editorial guidance.
Anti-D (Rh) immunoglobulin 250iu injection solution vial	A component that fails to comply with the current editorial guidance.
Anti-D (Rh) immunoglobulin 5000iu injection solution vial	A component that fails to comply with the current editorial guidance.
Anti-D (Rh) immunoglobulin 5000iu powder and solvent for injection solution vial	A component that fails to comply with the current editorial guidance.
Anti-D (Rh) immunoglobulin 5000iu powder for conventional release solution for injection vial	A component that fails to comply with the current editorial guidance.
Anti-D (Rh) immunoglobulin 500iu injection solution vial	A component that fails to comply with the current editorial guidance.
Anti-D (Rh) immunoglobulin 600iu powder and solvent for injection solution vial	A component that fails to comply with the current editorial guidance.
Anti-D (Rh) immunoglobulin 600iu powder for conventional release solution for injection vial	A component that fails to comply with the current editorial guidance.
Anti-D (Rh) immunoglobulin adverse reaction	Erroneous component (foundation metadata concept)
Anti-D (Rh) immunoglobulin injection	A component that fails to comply with the current editorial guidance.
Anti-D antibodies	Ambiguous
Anti-D globulin NOS	Erroneous component (foundation metadata concept)
Anti-D globulin NOS	Erroneous component (foundation metadata concept)
Anti-D globulin given	Erroneous component (foundation metadata concept)
Anti-D globulin given	Erroneous component (foundation metadata concept)
Anti-D globulin needed	Erroneous component (foundation metadata concept)
Anti-D globulin needed	Erroneous component (foundation metadata concept)
Anti-D immunoglobulin given	Erroneous component (foundation metadata concept)
Anti-D immunoglobulin given	Erroneous component (foundation metadata concept)
Anti-DNAse B antibody level	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-DNAse B antibody level	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-Hepatitis B immunoglobulin (& [given])	Ambiguous
Anti-IgA assay	Ambiguous
Anti-Rabies immunoglobulin	Ambiguous
Anti-T antibody	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-T antibody level	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-Tetanus immunoglobulin (& injection)	Ambiguous
Anti-androgens allergy	A component that fails to comply with the current editorial guidance.
Anti-brush border antibody	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-cardiolipin antibody level	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-cardiolipin antibody level	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-common cold drug poisoning of undetermined intent	A component that fails to comply with the current editorial guidance.
Anti-criminal psychotherapy	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-criminal psychotherapy NOS	Classification derived component
Anti-criminal psychotherapy NOS	Classification derived component
Anti-factor II disorder	Ambiguous
Anti-gastric acid drug overdose	Ambiguous
Anti-gastric acid drug poisoning	Ambiguous
Anti-gliadin IgA level	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-gliadin IgA level	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-gliadin IgA level	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-gliadin IgG level	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-gliadin IgG level	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-gliadin IgG level	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-gliadin antibody level	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-gliadin immunoglobulin A antibody level	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-gliadin immunoglobulin G antibody level	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-gout agent	A component that is no longer current, useful, appropriate or acceptable.
Anti-haemoglobin antibody level	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-heparin agent	A component that fails to comply with the current editorial guidance.
Anti-heparin agent	A component that fails to comply with the current editorial guidance.
Anti-hepatitis B immunoglobulin given	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-hyaluronidase	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-hyaluronidase assay	Ambiguous
Anti-infective nasal preparations adverse reaction	Ambiguous
Anti-infective nasal preparations allergy	A component that fails to comply with the current editorial guidance.
Anti-infective nasal preps.	A component that fails to comply with the current editorial guidance.
Anti-infective poisoning NOS	Limited component (foundation metadata concept)
Anti-infective preparations	A component that fails to comply with the current editorial guidance.
Anti-inflammat. light therapy	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-inflammatory agent	A component that fails to comply with the current editorial guidance.
Anti-inflammatory agent	A component that fails to comply with the current editorial guidance.
Anti-liver-kidney microsomal antibody level	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-myocardium antibody	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.

Start Previous Page 117 of 1411 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001066017	Concept inactivation indicator attribute value reference set	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001067014	Concept inactivation indicator reference set	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001068016	Concept inactivation indicator attribute value reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)